ZAP, US. Zomig for Appropriate for Primary Care
NCT00637286 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2009-04-06
Summary
The purpose of this study is to determine how useful and effective the use of ZOMIG-ZMT™ (zolmitriptan) 5.0 mg and ZOMIG® Nasal Spray (zolmitriptan) 5.0 mg is for patients, in treating migraine over a period of 6 months
Conditions
Interventions
- DRUG
-
Zolmitriptan
5mg Nasal Spray
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-07-31
- Completion
- 2005-05-31
More Related Trials
-
Study of PK, Safety, and Tolerability of 2 Lots of M207 & Intranasal Zolmitriptan in Healthy Volunteers
NCT04969497 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of M207 With Intranasal Zolmitriptan in Healthy Volunteers
NCT03708744 ·Status: COMPLETED ·Phase: PHASE1
-
A Four-way Crossover Study of 3 Formulations of M207 With Intranasal Zolmitriptan in Healthy Volunteers
NCT03978403 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications
NCT06401642 ·Status: RECRUITING ·Phase: PHASE4
-
Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers
NCT01085123 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine
NCT02745392 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants
NCT06103734 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
NCT06995729 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011)
NCT00442936 ·Status: COMPLETED ·Phase: PHASE3
-
Zolmitriptane as Prophylaxis for Chilhood Migraine
NCT06089356 ·Status: RECRUITING ·Phase: PHASE4
-
A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine Attack
NCT00530517 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Trial in Adult Participants With Acute Migraines
NCT04571060 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
NCT03282227 ·Status: COMPLETED ·Phase: PHASE3
-
Zonisamide Versus Topiramate in Migraine
NCT06347497 ·Status: RECRUITING ·Phase: PHASE3
-
Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches
NCT04066023 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of Sumatriptan and Placebo on CGRP Induced Headache
NCT03542357 ·Status: COMPLETED ·Phase: NA
-
Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine
NCT02605174 ·Status: COMPLETED ·Phase: PHASE3
-
Intranasal Civamide for Episodic Cluster Headache
NCT00069082 ·Status: COMPLETED ·Phase: PHASE3
-
Acute Migraine Treatment in the ED With Gepants
NCT06985342 ·Status: TERMINATED ·Phase: PHASE4
-
Acute Treatment Trial in Adult Subjects With Migraines
NCT03872453 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Trial of Comprehensive Migraine Intervention
NCT01071317 ·Status: COMPLETED ·Phase: PHASE4
-
Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers
NCT00720018 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention
NCT04804033 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults
NCT05989048 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache
NCT00055484 ·Status: COMPLETED ·Phase: PHASE2